Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 3/20 | 0.34 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.33 |
| ▸ | FEN1 | P39748 | 2/20 | 0.33 |
| ▸ | AR | P10275 | 9/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.30 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.30 |
| ▸ | MAT2A | P31153 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20111880 | 0.96 | AR (0.34) | RXRARXRGKIF11ALOX5APFEN1 | |
| SCHEMBL21258614 | 0.94 | ALOX5AP (0.35) | RXRARXRGKIF11ALOX5APFEN1 | |
| SCHEMBL21258598 | 0.93 | RXRA (0.34) | RXRARXRGKIF11ALOX5APFEN1 | |
| SCHEMBL20111601 | 0.93 | KIF11 (0.43) | KIF11ALOX5APFEN1ARDGAT1 | |
| SCHEMBL20111887 | 0.92 | PTPN5 (0.39) | ARPGRPTGDR2MAT2A | |
| SCHEMBL21258679 | 0.92 | AR (0.34) | RXRARXRGKIF11ALOX5APFEN1 | |
| SCHEMBL25658824 | 0.92 | KIF11 (0.36) | RXRARXRGKIF11ARNSD2 | |
| SCHEMBL25659757 | 0.92 | ALOX5AP (0.38) | RXRARXRGKIF11ALOX5APFEN1 | |
| SCHEMBL20111602 | 0.91 | KIF11 (0.34) | RXRARXRGKIF11ALOX5APFEN1 | |
| SCHEMBL20112007 | 0.91 | TRPA1 (0.35) | RXRARXRGKIF11ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10971688-B2 | Organic molecules for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2021-04-06 | — | — | US | disclosed |
| US-20190248741-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-15 | — | — | US | disclosed |
| WO-2018077492-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10971688-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OPRM1 | RXRA 1755/4885RXRG 1424/4885KIF11 3426/4885 |
| US-20190248741-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | RXRA 3082/4885RXRG 2888/4885KIF11 3661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.